| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 462.6K | $12.49M | - | |
| Other | 223.5K | $6.03M | - | |
| Other | 142.5K | $3.85M | - | |
| Other | 51.4K | $1.39M | - | |
| CFO | 18.1K | $490.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2021 | Thomas Andrew Crockett72 | CEO | Sell | 10,000 | $17.18 | $171,841.00 | -7.4% | -21.6% | -16.3% | |
| Aug 2, 2021 | Christopher Yea53 | Chief Development Officer | Sell | 5,000 | $20.52 | $102,578.50 | -11.6% | -10.8% | -40.4% | |
| Aug 2, 2021 | Edward P. Feener72 | Chief Scientific Officer | Sell | 6,000 | $20.52 | $123,133.80 | -42.2% | -10.8% | -40.4% | |
| Jul 1, 2021 | Thomas Andrew Crockett72 | CEO | Sell | 10,000 | $24.15 | $241,476.96 | -6.9% | -30.1% | -59.6% | |
| Jun 17, 2021 | Thomas Andrew Crockett72 | CEO | Sell | 1,067 | $30.04 | $32,050.55 | -0.7% | -35.6% | -69.5% | |
| Jun 9, 2021 | Thomas Andrew Crockett72 | CEO | Sell | 8,933 | $30.05 | $268,480.42 | -5.8% | -30.0% | -70.8% | |
| Jun 2, 2021 | Edward P. Feener72 | Chief Scientific Officer | Sell | 34,000 | $26.72 | $908,360.70 | -70.5% | -23.3% | -67.4% | |
| Jun 1, 2021 | Michael David Smith | Senior VP, Development | Sale+OE | 7,500 | $26.83 | $201,221.25 | - | -25.2% | -67.6% | |
| May 3, 2021 | Christopher Yea53 | Chief Development Officer | Sell | 5,000 | $24.84 | $124,196.50 | -10.4% | -18.1% | -47.4% | |
| May 3, 2021 | Edward P. Feener72 | Chief Scientific Officer | Sale+OE | 6,000 | $24.84 | $149,050.80 | -10.0% | -18.1% | -47.4% |